Page 9 - Roivant Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Research Analysts’ updated eps estimates for Monday, March 25th: Absci (NASDAQ:ABSI) had its outperform rating reaffirmed by analysts at Scotiabank. They currently have a $13.00 price target on the stock. Aehr Test Systems (NASDAQ:AEHR) had its market perform rating reissued by analysts at William Blair. American Healthcare REIT (NYSE:AHR) had its market outperform rating reaffirmed […]

Research Analysts’ updated eps estimates for Monday, March 25th: Absci (NASDAQ:ABSI) had its outperform rating reaffirmed by analysts at Scotiabank. They currently have a $13.00 price target on the stock. Aehr Test Systems (NASDAQ:AEHR) had its market perform rating reissued by analysts at William Blair. American Healthcare REIT (NYSE:AHR) had its market outperform rating reaffirmed […]

Relief Therapeutics (OTCMKTS:RLFTF – Get Free Report) and Roivant Sciences (NASDAQ:ROIV – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, risk, institutional ownership, valuation, analyst recommendations and dividends. Analyst Ratings This is a breakdown of recent […]

Explore the best 50 jobs for career change with our comprehensive guide. Explore top career options and make informed decisions for your professional transition today!

Deerfield Management Company L.P. Series C raised its position in Roivant Sciences Ltd. (NASDAQ:ROIV – Free Report) by 18.4% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,604,487 shares of the company’s stock after acquiring an additional 249,513 shares during […]